# A Prospective Trial of Nasal Mupirocin, Hexachlorophene Body Wash, and Systemic Antibiotics for Prevention of Recurrent Methicillin Resistant Staphylococcus Aureus Infections

> **NCT01049438** · NA · COMPLETED · sponsor: **Natividad Medical Center** · enrollment: 31 (actual)

## Conditions studied

- Methicillin Resistant Staphylococcus Aureus Skin Infections

## Interventions

- **DRUG:** nasal mupirocin
- **DRUG:** topical 3% hexachlorophene body wash
- **DRUG:** oral anti-MRSA antibiotic

## Key facts

- **NCT ID:** NCT01049438
- **Lead sponsor:** Natividad Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2010-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01049438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01049438, "A Prospective Trial of Nasal Mupirocin, Hexachlorophene Body Wash, and Systemic Antibiotics for Prevention of Recurrent Methicillin Resistant Staphylococcus Aureus Infections". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01049438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*